Literature DB >> 17728477

Comparison between disk diffusion and microdilution methods for determining susceptibility of clinical fungal isolates to caspofungin.

Maria Eleonora Milici1, Carmelo Massimo Maida, Elisabetta Spreghini, Barbara Ravazzolo, Salvatore Oliveri, Giorgio Scalise, Francesco Barchiesi.   

Abstract

We compared the caspofungin (CAS) susceptibility testing results generated by the disk diffusion (DD) assay with the results of the Clinical and Laboratory Standards Institute (CLSI) broth microdilution (BD) reference method for 106 yeast isolates. The isolates represented 11 different fungal species, including Candida albicans (n = 50), C. parapsilosis (n = 10), C. glabrata (n = 10), C. tropicalis (n = 10), C. guillermondii (n = 6), C. rugosa (n = 5), C. krusei (n = 5), C. kefyr (n = 2), C. pelliculosa (n = 2), Saccharomyces cerevisiae (n = 3), and Geotrichum candidum (n = 3). The DD assay was performed in supplemented Mueller-Hinton agar with CAS, which was tested at concentrations of 2, 10, and 25 mug per disk. MICs and inhibition zone diameters were evaluated at 24 and 48 h. In general, the results obtained by the DD assay correlated well with those obtained by the BD method. In particular, a significant correlation between methods was observed when CAS was used at concentration of 2 mug/disk at a reading time of either 24 or 48 h.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17728477      PMCID: PMC2168513          DOI: 10.1128/JCM.00826-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  In vitro activity of the new echinocandin antifungal, MK-0991, against common and uncommon clinical isolates of Candida species.

Authors:  F Barchiesi; A M Schimizzi; A W Fothergill; G Scalise; M G Rinaldi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-04       Impact factor: 3.267

2.  Disk diffusion method for determining susceptibilities of Candida spp. to MK-0991.

Authors:  M Lozano-Chiu; P W Nelson; V L Paetznick; J H Rex
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

3.  Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species.

Authors:  Frank C Odds; Mary Motyl; Roberto Andrade; Jacques Bille; Emilia Cantón; Manuel Cuenca-Estrella; Amanda Davidson; Christian Durussel; David Ellis; Elyse Foraker; Annette W Fothergill; Mahmoud A Ghannoum; Robert A Giacobbe; Miguel Gobernado; Rosemary Handke; Michel Laverdière; Wendy Lee-Yang; William G Merz; Luis Ostrosky-Zeichner; Javier Pemán; Sophia Perea; John R Perfect; Michael A Pfaller; Laurie Proia; John H Rex; Michael G Rinaldi; Juan-Luis Rodriguez-Tudela; Wiley A Schell; Christine Shields; Deanna A Sutton; Paul E Verweij; David W Warnock
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

4.  Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole.

Authors:  A Espinel-Ingroff; E Canton; D Gibbs; A Wang
Journal:  J Clin Microbiol       Date:  2007-01-10       Impact factor: 5.948

5.  Evaluation of disk diffusion method for determining posaconazole susceptibility of filamentous fungi: comparison with CLSI broth microdilution method.

Authors:  E López-Oviedo; A I Aller; C Martín; C Castro; M Ramirez; J M Pemán; E Cantón; C Almeida; E Martín-Mazuelos
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

6.  Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.

Authors:  A Espinel-Ingroff; B Arthington-Skaggs; N Iqbal; D Ellis; M A Pfaller; S Messer; M Rinaldi; A Fothergill; D L Gibbs; A Wang
Journal:  J Clin Microbiol       Date:  2007-04-11       Impact factor: 5.948

7.  Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.

Authors:  M A Pfaller; L Boyken; S A Messer; S Tendolkar; R J Hollis; D J Diekema
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

8.  Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome.

Authors:  Nicholas Kartsonis; John Killar; Lori Mixson; Chao-Min Hoe; Carole Sable; Kenneth Bartizal; Mary Motyl
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

Review 9.  Caspofungin: the first in a new class of antifungal agents.

Authors:  Nicholas A Kartsonis; Jennifer Nielsen; Cameron M Douglas
Journal:  Drug Resist Updat       Date:  2003-08       Impact factor: 18.500

10.  In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance.

Authors:  M A Pfaller; L Boyken; R J Hollis; S A Messer; S Tendolkar; D J Diekema
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

View more
  6 in total

1.  Evaluation of the disk diffusion method compared to the microdilution method in susceptibility testing of anidulafungin against filamentous fungi.

Authors:  Carmelo Massimo Maida; Maria Eleonora Milici; Laura Trovato; Salvatore Oliveri; Emanuele Amodio; Elisabetta Spreghini; Giorgio Scalise; Francesco Barchiesi
Journal:  J Clin Microbiol       Date:  2008-10-15       Impact factor: 5.948

2.  Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin.

Authors:  M A Pfaller; V Chaturvedi; D J Diekema; M A Ghannoum; N M Holliday; S B Killian; C C Knapp; S A Messer; A Miskov; R Ramani
Journal:  J Clin Microbiol       Date:  2008-05-07       Impact factor: 5.948

3.  Comparative Analysis of Disc Diffusion and E-test with Broth Micro-dilution for Susceptibility Testing of Clinical Candida Isolates Against Amphotericin B, Fluconazole, Voriconazole and Caspofungin.

Authors:  Deepak Kumar; Sayan Bhattacharyya; Prashant Gupta; Gopa Banerjee; Mastan Singh
Journal:  J Clin Diagn Res       Date:  2015-11-01

4.  Pre-mRNA splicing is modulated by antifungal drugs in the filamentous fungus Neurospora crassa.

Authors:  Niege S Mendes; Patricia M Silva; Rafael Silva-Rocha; Nilce M Martinez-Rossi; Antonio Rossi
Journal:  FEBS Open Bio       Date:  2016-03-14       Impact factor: 2.693

5.  Intra-abdominal Candida spp infection in acute abdomen in a quality assurance (QA)-certified academic setting.

Authors:  Vito Rodolico; Paola Di Carlo; Gaspare Gulotta; Francesco D'Arpa; Giuseppe Salamone; Gianfranco Cocorullo; Antonino Agrusa; Anna Giammanco; Consolato Sergi
Journal:  J Clin Pathol       Date:  2016-12-09       Impact factor: 3.411

6.  Antifungal susceptibility of non-albicans Candida spp. isolated from raw milk and human blood in Alborz and Tehran provinces.

Authors:  Zahra Namvar; Abbas Akhavan Sepahy; Robab Rafiei Tabatabaei; Sassan Rezaie
Journal:  Iran J Microbiol       Date:  2019-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.